ABI Advanced Gene Expression Service Provider Program Expands Globally
News Feb 13, 2006
Applied Biosystems, an Applera Corporation business, has announced its Advanced Gene Expression Service Provider Program has expanded globally with the addition of eleven microarray service provider centers throughout North America, Europe, and Asia.
As part of their participation, the eleven companies and academic centers will offer Applied Biosystems microarray gene expression tools and services, including microarrays for human, mouse, and rat genes to enhance service providers’ business offerings.
The Program also includes technical support that is expected to enhance their ability to deliver advanced gene expression services to clients.
Researchers taking advantage of the microarray services will have the option to validate data from the Applied Biosystems microarrays using Applied Biosystems TaqMan® Gene Expression Assays and Real-Time PCR Systems.
"Microarray analysis is a major area of focus for our institution," said Shawn Levy, Ph.D., Director, Vanderbilt Microarray Shared Resource at Vanderbilt University.
"Participation in the Program will allow us to make strategic investment in our gene expression technology platform and realize a significant return through a service that will provide our researchers access to the most annotated gene content available and the highest-quality results."
"Applied Biosystems offers the broadest gene expression portfolio," added Mirko Vanetti, Ph.D., CEO of IMGM Laboratories and one of the first Program collaborators.
"We have already seen initial success with the Applied Biosystems Expression Array System offerings which allows us to combine our medical expertise with some of the best technologies available on the market."
"For example, the tools offered in the Program are helping us identify customer gene signatures that may ultimately lead to a diagnostic test for Alzheimer’s disease."
The latest additions to Applied Biosystems Advanced Gene Expression Service Provider Program include: Bionomics Research and Technology Center at the University of Medicine and Dentistry of New Jersey and Rutgers University (USA); Geneservice Limited (UK); Genome Express (France); IMGM Laboratories (Germany); Labindia (India); Macrogen (South Korea); Center for Medical Research, Medical University Graz (Austria); Ming Shin Biotech (Taiwan); Trinity College Dublin (Ireland); Norwegian Microarray Consortium, University of Bergen (Norway); and Vanderbilt Shared Microarray Resource (USA).
"Applied Biosystems is pleased to announce the expansion of our Advanced Gene Expression Service Provider Program with the addition of service providers from around the globe," said William V. Murray, Division President of Molecular Biology for Applied Biosystems.
"Through this program, these companies and academic centers can confidently offer clients the most complete gene content for microarray expression analysis while backing it up with technical and marketing support from a leading provider of gene expression technologies."
Additional data analysis and marketing support is included with the Applied Biosystems Advanced Gene Expression Service Provider Program.
Participants will have access to the PANTHER™ Protein Classification System, a Service Provider web link on the Applied Biosystems Website, marketing collateral material development, and educational seminars.
Genetic Diversity Helps Protect Against DiseaseNews
Why do populations have genetic diversity when 'Survival of the Fittest' suggests that only one gene pool should thrive? It's a question that is hard to answer experimentally. A new study looking at evolutionary change in real time in tiny fungal parasites may provide a solution.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE